Cargando…

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

The outbreak of coronavirus disease 2019 (COVID-19) represented a new worldwide challenge, strongly impacting on the global economy, overall health and lifestyle. Since then, several strategies have been adopted to contain the widespread of infection. Among these, vaccination is currently the most i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martora, Fabrizio, Battista, Teresa, Marasca, Claudio, Genco, Lucia, Fabbrocini, Gabriella, Potestio, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648179/ https://www.ncbi.nlm.nih.gov/pubmed/36387962 http://dx.doi.org/10.2147/CCID.S388245

Ejemplares similares

COVID‐19 vaccination and inflammatory skin diseases
por: Martora, Fabrizio, et al.
Publicado: (2022)

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
por: Potestio, Luca, et al.
Publicado: (2023)

COVID‐19 and cutaneous manifestations: A review of the published literature
por: Martora, Fabrizio, et al.
Publicado: (2022)

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series
por: Martora, Fabrizio, et al.
Publicado: (2022)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
por: Martora, Fabrizio, et al.
Publicado: (2023)

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511”
por: Potestio, Luca, et al.
Publicado: (2022)

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
por: Potestio, Luca, et al.
Publicado: (2023)

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series
por: Martora, Fabrizio, et al.
Publicado: (2021)

The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature
por: Martora, Fabrizio, et al.
Publicado: (2023)

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge
por: Potestio, Luca, et al.
Publicado: (2023)

Herpes zoster and alopecia areata following mRNA BNT162b2 COVID‐19 vaccine: Controversial immune effects
por: Martora, Fabrizio, et al.
Publicado: (2022)

Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
por: Martora, Fabrizio, et al.
Publicado: (2023)

Pemphigus vulgaris and COVID‐19 vaccination: Management and treatment
por: Martora, Fabrizio, et al.
Publicado: (2022)

Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
por: Battista, Teresa, et al.
Publicado: (2023)

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19
por: Martora, Fabrizio, et al.
Publicado: (2023)

Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
por: Martora, Fabrizio, et al.
Publicado: (2023)

Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Onset of vitiligo in a psoriasis patient on ixekizumab
por: Marasca, Claudio, et al.
Publicado: (2021)

How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
por: Potestio, Luca, et al.
Publicado: (2023)

Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication
por: Napolitano, Maddalena, et al.
Publicado: (2022)

A Case of New-Onset Lichen Planus after COVID-19 Vaccination
por: Picone, Vincenzo, et al.
Publicado: (2022)

Alopecia Areata after COVID-19 Vaccines
por: Genco, Lucia, et al.
Publicado: (2023)

Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study
por: Megna, Matteo, et al.
Publicado: (2023)

“Covid arm”: Abnormal side effect after Moderna COVID‐19 vaccine
por: Picone, Vincenzo, et al.
Publicado: (2021)

A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine
por: Martora, Fabrizio, et al.
Publicado: (2022)

A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa
por: Marasca, Claudio, et al.
Publicado: (2018)

Guselkumab-induced vitiligo in a patient with psoriatic arthritis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Impact of COVID‐19 pandemic and the use of telemedicine on the diagnosis and treatment of tinea corporis: An experience of Southern Italy center
por: Picone, Vincenzo, et al.
Publicado: (2022)

Chronic cutaneous ulcers management in dermatologic department during COVID‐19 era
por: Zagaria, Orlando, et al.
Publicado: (2020)

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
por: Megna, Matteo, et al.
Publicado: (2023)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
por: Martora, Fabrizio, et al.
Publicado: (2023)

A case of scalp psoriasis resistant to ixekizumab treated with bimekizumab
por: Megna, Matteo, et al.
Publicado: (2023)

Herpes Zoster and COVID-19 Vaccination: A Narrative Review
por: Potestio, Luca, et al.
Publicado: (2023)

New‐onset lichen planus arising after COVID‐19 vaccination
por: Zagaria, Orlando, et al.
Publicado: (2022)

“PiMa sign”: A possible correlation between dermographism and pityriasis versicolor?
por: Martora, Fabrizio, et al.
Publicado: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2un9uueinaukcbppm08ve2sa2c